首页> 外文期刊>Biotechnology Law Report >Guidance for Industry Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology
【24h】

Guidance for Industry Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology

机译:考虑FDA管制产品是否涉及纳米技术应用的行业指南

获取原文
获取原文并翻译 | 示例
           

摘要

This guidance is intended for manufacturers, suppliers, importers and other stakeholders. The guidance describes FDA's current thinking on whether FDA-regulated products2 contain nanomateri.al.sor otherwise involve the application of nanotechnology. FDA's guidance documents, including this guidance, do not establish legally enforceable responsibilities...This guidance document does not establish any regulatory definitions. Rather, it is intended to help industry and others identify when they should consider potential implications for regulatory status, safety, effectiveness, or public health impact thatmay arise with the application of nanotechnology in FDA-regulated products. Public input on the guidance may also inform the development of any regulatory definitions in the future, as needed.
机译:本指南适用于制造商,供应商,进口商和其他利益相关者。该指南描述了FDA当前关于FDA管制产品2是否包含纳米材料的想法,否则涉及纳米技术的应用。 FDA的指南文件(包括本指南)未确立法律上可强制执行的责任...本指南文件未建立任何法规定义。相反,它旨在帮助行业和其他机构确定何时应考虑将纳米技术应用于FDA监管产品可能对监管状态,安全性,有效性或公共健康产生潜在影响。根据需要,公众对指南的投入也可能会为将来任何法规定义的制定提供信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号